Safety of Total Daily Doses of Polyethylene Glycol (PEG) 400 Administered Orally to Healthy Male Human Subjects
Clinical trial NCT02260076 · COMPLETED
Trial details
- NCT number
- NCT02260076
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2001-09-01
- Primary completion
- 2002-03-01
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.